Vestnik Transplantologii i Iskusstvennyh Organov

Scope & Guideline

Empowering collaboration in the science of transplantation.

Introduction

Delve into the academic richness of Vestnik Transplantologii i Iskusstvennyh Organov with our guidelines, detailing its aims and scope. Our resource identifies emerging and trending topics paving the way for new academic progress. We also provide insights into declining or waning topics, helping you stay informed about changing research landscapes. Evaluate highly cited topics and recent publications within these guidelines to align your work with influential scholarly trends.
LanguageRussian
ISSN1995-1191
PublisherFEDERAL RESEARCH CENTER TRANSPLANTOLOGY & ARTIFICIAL ORGANS V I SHUMAKOV
Support Open AccessYes
CountryRussian Federation
TypeJournal
Convergefrom 2015 to 2024
AbbreviationVESTN TRANSPL ISKUSS / VESTN. TRANSPL. ISKUSSTV. ORGANOV.
Frequency4 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressUL SHCHUKINSKAYA, D 1, MOSCOW 123182, RUSSIA

Aims and Scopes

The journal "Vestnik Transplantologii i Iskusstvennyh Organov" primarily focuses on advancing knowledge and research in the field of transplantology and artificial organ development. It serves as a platform for sharing innovative methodologies, clinical practices, and technological advancements in organ transplantation.
  1. Transplantation Techniques and Outcomes:
    The journal emphasizes the latest surgical techniques, outcomes, and innovations in organ transplantation, including heart, kidney, liver, and lung transplants.
  2. Artificial Organ Development:
    There is a significant focus on the creation and optimization of artificial organs and tissue engineering, highlighting advancements in biocompatibility and functional integration.
  3. Regenerative Medicine:
    Research in regenerative medicine is a core area, with studies on stem cells, tissue engineering, and cellular therapies aimed at improving transplant outcomes.
  4. Immunology and Rejection Mechanisms:
    The journal discusses immunological factors influencing transplant success, including rejection mechanisms and the use of immunosuppressive therapies.
  5. Ethics and Policy in Organ Donation:
    The journal also addresses ethical considerations and policy developments surrounding organ donation and transplantation practices, particularly within the Russian Federation.
Recent publications in the journal reflect evolving trends and emerging themes in the field of transplantology and artificial organs. This section outlines these key areas of growth and interest.
  1. Machine Perfusion Techniques:
    There is an increasing emphasis on machine perfusion techniques, particularly for organ preservation and transplantation, which is seen as a critical area for improving graft outcomes.
  2. 3D Bioprinting and Tissue Engineering:
    The journal is seeing a rise in research focusing on 3D bioprinting technologies for creating complex tissue structures, which could revolutionize organ transplantation.
  3. Long-Term Outcomes and Quality of Life Studies:
    Emerging research is focusing more on long-term patient outcomes and quality of life post-transplant, reflecting a holistic approach to transplant medicine.
  4. Nanotechnology in Transplantation:
    The application of nanotechnology in improving biocompatibility and reducing rejection rates in transplant procedures is gaining traction among recent publications.
  5. Personalized Medicine in Transplant Protocols:
    There is a trend towards personalized medicine, with studies exploring tailored immunosuppressive regimens based on genetic and phenotypic patient factors.

Declining or Waning

While certain themes remain central to the journal's focus, others appear to be diminishing in prominence. This section identifies areas that have shown a decline in recent publications.
  1. Traditional Organ Preservation Techniques:
    There is a noticeable decrease in papers discussing conventional organ preservation methods, as the field shifts towards more innovative techniques like hypothermic machine perfusion.
  2. Clinical Case Reports:
    The number of clinical case reports has declined, indicating a potential shift towards more systematic reviews and experimental studies rather than individual case analyses.
  3. Basic Science Studies Without Clinical Relevance:
    Research that does not directly translate into clinical applications or innovations in transplantation is less frequently featured, as the journal prioritizes studies with clear clinical implications.

Similar Journals

International Journal of Stem Cells

Catalyzing Innovations in Stem Cell Applications
Publisher: KOREAN SOC STEM CELL RESEARCHISSN: 2005-3606Frequency: 2 issues/year

The International Journal of Stem Cells is a distinguished peer-reviewed journal dedicated to advancing the field of stem cell research. Published by the Korean Society for Stem Cell Research, this journal has established itself as a vital source of high-quality research since its inception in 2008. Operating under the ISSN 2005-3606 and E-ISSN 2005-5447, the journal caters to a global audience, featuring works that span a diverse array of topics within Cell Biology and Developmental Biology. It is noteworthy that as of 2023, the journal is ranked Q3 in Cell Biology and Q2 in Developmental Biology, highlighting its growing influence and credibility in the scientific community. Given its commitment to facilitating open scientific communication, it is crucial for researchers, professionals, and students to engage with the rigorous research published in this journal as it profoundly impacts the understanding and application of stem cell science. With accessibility to a wealth of innovative studies, the International Journal of Stem Cells remains an indispensable resource for anyone interested in the transformative potential of stem cell research.

Current Opinion in Organ Transplantation

Exploring Innovations in Transplant Medicine
Publisher: LIPPINCOTT WILLIAMS & WILKINSISSN: 1087-2418Frequency: 6 issues/year

Current Opinion in Organ Transplantation, published by Lippincott Williams & Wilkins, serves as a leading journal in the fields of immunology and transplantation, providing insightful reviews and expert opinions that shape the discourse in these vital areas of medical research. With an impact factor showcasing its significance and influence in the academic community, this journal is ranked in the Q2 category for both Immunology and Transplantation according to the 2023 metrics, affirming its essential role in advancing knowledge and understanding. Spanning from its inception in 2001 through to 2024, Current Opinion in Organ Transplantation offers a platform for researchers, professionals, and students to engage with the latest advancements and trends, contributing to the ongoing dialogue that drives innovation in organ transplantation and immunological therapies. Although the journal does not currently offer open access options, its rigorous peer-review process and reputable publisher ensure the highest quality of research dissemination, making it an invaluable resource for those invested in the future of organ transplantation.

TRANSPLANT INTERNATIONAL

Empowering Knowledge for Better Patient Outcomes
Publisher: FRONTIERS MEDIA SAISSN: 0934-0874Frequency: 1 issue/year

TRANSPLANT INTERNATIONAL is a premier open-access journal in the field of transplantation, published by Frontiers Media SA since 1988. With its dedicated scope encompassing the latest research and advancements in organ transplantation and related fields, this journal serves as an essential resource for researchers, clinicians, and healthcare professionals engaged in transplantation medicine. Boasting an impressive 2023 Scopus rank of #17 out of 54 in the Medicine - Transplantation category and a Q2 quartile ranking, it has established itself as a vital publication platform contributing to the global discourse on transplant innovations. As an open-access journal since 2022, TRANSPLANT INTERNATIONAL enhances the dissemination of knowledge, ensuring that pivotal findings are accessible to a broader audience, thereby fostering advancements in patient care and clinical practices. With its base in Italy and operations managed from Lausanne, Switzerland, the journal promises to remain at the forefront of transplantation research through 2024 and beyond.

Organogenesis

Unveiling the Complexities of Organogenesis.
Publisher: TAYLOR & FRANCIS INCISSN: 1547-6278Frequency: 4 issues/year

Organogenesis is a leading journal published by Taylor & Francis Inc, dedicated to advancing the field of developmental biology and regenerative medicine. With an ISSN of 1547-6278 and E-ISSN 1555-8592, this journal spans an extensive research scope that includes embryology, transplantation, and biomedical engineering, distinguishing itself as a crucial platform for researchers and practitioners alike. Its impact is reflected in its performance across various categories in 2023, earning Q3 rankings in Biomedical Engineering and Embryology, Q4 in Developmental Biology, and Q2 in Transplantation, showcasing its reputable standing among peer journals. Moreover, with Scopus rankings indicating strong positioning in the fields of medicine and biochemistry, Organogenesis is essential for those looking to publish or stay updated on pioneering research. The journal facilitates rigorous peer-review and offers a forum for disseminating innovative findings, making it an invaluable resource for academics, professionals, and students committed to understanding the complexities of organism development.

Indian Journal of Transplantation

Unlocking Insights in Transplantation Science
Publisher: WOLTERS KLUWER MEDKNOW PUBLICATIONSISSN: 2212-0017Frequency: 4 issues/year

Indian Journal of Transplantation (ISSN: 2212-0017, E-ISSN: 2212-0025), published by Wolters Kluwer Medknow Publications, serves as a pivotal resource in the expanding field of transplantation medicine. As an Open Access journal since 2011, it provides unrestricted access to cutting-edge research, facilitating the dissemination of knowledge among practitioners, researchers, and students globally. With a growing focus on transplant-related advancements from 2020 to 2024, the journal has positioned itself within the Q4 category in Transplantation, underscoring its commitment to publishing valuable contributions that aim to enhance clinical practices and improve patient outcomes. Situated in the Netherlands, the journal upholds high-quality standards, inviting submissions that contribute to the understanding of various transplant procedures and practices, ultimately fostering innovation in the field. Researchers and professionals are encouraged to explore the vast array of articles, enhancing both their expertise and the community's collective knowledge in transplantation.

Progress in Transplantation

Elevating Standards in Transplantation Medicine
Publisher: SAGE PUBLICATIONS INCISSN: 1526-9248Frequency: 4 issues/year

Progress in Transplantation is a leading journal published by SAGE Publications Inc, focusing on the dynamic field of transplantation medicine. With an ISSN of 1526-9248 and E-ISSN 2164-6708, this journal serves as a crucial platform for researchers and clinicians aiming to share cutting-edge findings and advancements in organ transplantation. Despite not being an Open Access journal, it provides a significant contribution to the academic community, evidenced by its placement in the Q3 category of Transplantation for 2023 and its ranking of #33 out of 54 in Scopus, showcasing a percentile standing of 39th. Progress in Transplantation has been dedicated to publishing high-quality research since its inception in 2000, and it continues to be a vital resource for those seeking to enrich their knowledge and foster innovation within the field of transplantation, fostering collaboration among practitioners, researchers, and students alike.

Transplantation Direct

Pioneering Open Access Solutions in Transplantation Science
Publisher: LIPPINCOTT WILLIAMS & WILKINSISSN: 2373-8731Frequency: 12 issues/year

Transplantation Direct is a leading open access journal in the field of transplantation, published by the prestigious Lippincott Williams & Wilkins. Since its inception in 2015, the journal has provided a vital platform for the dissemination of high-quality research and advancements related to organ transplantation. With an impact factor that places it in the Q2 category among transplantation journals, it ranks #22 out of 54 in the Medicine - Transplantation Scopus classification, reflecting its significance and authority within the discipline. The journal not only covers a broad scope of topics related to transplantation but also encourages global collaboration and knowledge exchange amongst researchers, clinicians, and students. With its open access model, Transplantation Direct ensures that groundbreaking findings are accessible to a wider audience, fostering innovation and enhancing patient care worldwide. For more information, visit their address at TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103.

Transplantation Reviews

Advancing transplantation science through cutting-edge research.
Publisher: ELSEVIER SCIENCE INCISSN: 0955-470XFrequency: 4 issues/year

Transplantation Reviews is a premier scholarly journal published by Elsevier Science Inc, dedicated to advancing the field of transplantation and surgery. With an impressive impact factor and categorized in the top quartile (Q1) for both Surgery and Transplantation as of 2023, this journal prominently ranks in the 96th and 86th percentiles for its respective disciplines. Since its inception in 1987, it has provided a vital platform for researchers and professionals to disseminate high-quality, peer-reviewed articles that reflect the latest advancements and challenges in transplantation science. Although the journal is not currently open access, it remains a key resource for academic libraries and institutions. By fostering discussions and providing insights into clinical practices, Transplantation Reviews serves to enhance understanding and improve outcomes in the ever-evolving field of transplantation, making it an essential read for anyone engaged in this dynamic area of medicine.

Tissue Engineering Part A

Transforming Laboratory Discoveries into Clinical Solutions
Publisher: MARY ANN LIEBERT, INCISSN: 1937-3341Frequency: 24 issues/year

Tissue Engineering Part A is a prestigious peer-reviewed journal published by MARY ANN LIEBERT, INC that focuses on innovative research and advancements within the field of tissue engineering and regenerative medicine. Since its inception in 2008, this journal has played a critical role in disseminating cutting-edge findings that bridge the gap between laboratory research and clinical application, underscoring its significance in the scientific community. With a diverse scope encompassing biochemistry, bioengineering, biomaterials, and biomedical engineering, the journal ranks notably in the Scopus database, holding a Q2 quartile status across multiple categories, thus reflecting its high impact on ongoing research and professional practice. For researchers, professionals, and students, Tissue Engineering Part A serves as an invaluable resource, offering insights into the latest methodologies and breakthroughs that drive the future of healthcare and therapeutic strategies. While primarily a subscription-based journal, it ensures that vital research is accessible to a broad audience of scientists and engineers committed to advancing the life sciences.

CELLS TISSUES ORGANS

Exploring the Intricacies of Cells, Tissues, and Organs.
Publisher: KARGERISSN: 1422-6405Frequency: 6 issues/year

CELLS TISSUES ORGANS is a renowned academic journal published by KARGER, focusing on pivotal research within the fields of Anatomy and Histology. Based in Switzerland, this journal has been disseminating influential scientific findings since 1889, contributing to our understanding of cellular structures and tissue functionality. With a current impact factor that places it in the Q2 quartile for both disciplines, it serves as a vital resource for researchers, professionals, and students seeking to stay abreast of significant advancements and discussions in these areas. The journal embraces an Open Access model, ensuring that high-quality, peer-reviewed articles are freely available, thus enhancing visibility and accessibility of critical research. As it continues to foster scholarly communication and innovation up to 2024, CELLS TISSUES ORGANS plays a crucial role in shaping the future of biological sciences and medical research.